High availability of intravascular tissue factor in neonates

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 5, 2007, Pages 279-283

  Cvirn, Gerhard ^a   Gruber, Hans Juergen ^a   Koestenberger, Martin ^a   Kutschera, Joerg ^a   Wagner, Thomas ^a   Ferstl, Ulrika ^a   Sedlmayr, Peter ^a   Juergens, Guenther ^a   Gallistl, Siegfried ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cord and adult whole blood; Flow cytometric analysis; Intravascular tissue factor; Monocytes; Quantitative reverse transcription polymerase chain reaction; Thrombelastography

Indexed keywords

BETA ACTIN; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; FLUORESCENCE ACTIVATED CELL SORTING; HOUSEKEEPING GENE; HUMAN; INCUBATION TIME; MALE; MONOCYTE; NEWBORN; NEWBORN PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOELASTOGRAPHY; UMBILICAL CORD BLOOD;

ADULT; AGE FACTORS; BLOOD COAGULATION; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INFANT, NEWBORN; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; THROMBELASTOGRAPHY; THROMBOPLASTIN; WHOLE BLOOD COAGULATION TIME;

EID: 34248189777     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31804bdb12     Document Type: Article

References (34)

1. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70:165-172.
2. Andrew M, Schmidt B, Mitchell L, et al. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost. 1990;63:27-30.
3. David M, Andrew M. Venous thromboembolic complications in children. J Pediatr. 1993;123:337-346.
4. Chan AK, Deveber G, Monagle P, et al. Venous thrombosis in children. J Thromb Haemost. 2003;1:1443-1455.
5. Cvirn G, Gallistl S, Leschnik B, et al. Low tissue factor pathway inhibitor together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost. 2003;1:263-268.
6. Cvirn G, Koestenberger M, Leschnik B, et al. Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults. Brit J Pharmacol. 2005;146:1082-1086.
7. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311-2315.
8. Osterud B. Tissue factor expression in monocytes: in vitro compared to ex vivo. Thromb Haemost. 2000;84:521-522.
9. Müller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J. 2003;17: 476-478.
10. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol. 1990;12:95-104.
11. Rajasekhar D, Kestin AS, Bednarek FJ, et al. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost. 1994;72:957-963.
12. Reverdiau-Moalic P, Delahousse B, Body G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood. 1996;88:900-906.
13. Pfaffl MW. A new mathematical model for relative quantification in real time RT-PCR. Nucleic Acid Res. 2001;29:e45.
14. Mälarstig A, Tenno T, Jossan S, et al. A quantitative real-time PCR method for tissue factor mRNA. Thromb Res. 2003;112:175-183.
15. Sorensen B, Johansen P, Christiansen K, et al. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost. 2003;1:551-558.
16. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004;24:1015-1022.
17. Butenas S, Bouchard BA, Brummel-Ziedins KE, et al. Tissue factor activity in whole blood. Blood. 2005;105:2764-2770.
18. Vijaya Mohan Rao L, Pendurthi UR. Tissue factor-factor VIIa signalling. Arterioscler Thromb Vasc Biol. 2005;25:47-56.
19. Van 't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin III, and heparin cofactor II. J Biol Chem. 1997;272:4367-4377.
20. Hockin MF, Jones KC, Everse SJ, et al. A model for the stoichiometric regulation of blood coagulation. J Biol Chem. 2002;277:18322-18333.
21. Rivers RPA, Cattermole HEJ, Wright I. The expression of surface tissue factor apoprotein by blood monocytes in the course of infections in early infancy. Pediatr Res. 1992;31:567-573.
22. Amirkhosravi A, Alexander M, May K, et al. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost. 1996;75:87-95.
23. Osterud B. The high responder phenomenon: enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes. Platelets. 1995;6:119-125.
24. Egorina EM, Sovershaev MA, Bjorkoy G, et al. Intracellular and surface distribution of monocyte tissue factor. Arterioscler Thromb Vasc Biol. 2005;25:1493-1498.
25. Weinberg AG, Rosenfeld CR, Manroe BL, et al. Neonatal blood cell count in health and disease. II. Values for lymphocytes, monocytes, and eosinophils. J Pediatr. 1985;106:462-466.
26. Streif W, Paes B, Berry L, et al. Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns. Blood Coagul Fibrinolysis. 2000;11:349-357.
27. Fischer BE, Kramer G, Mitterer A, et al. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII. Thromb Res. 1996;84:55-66.
28. Rehak T, Cvirn G, Gallistl S, et al. Increased shear stress- and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma. Thromb Haemost. 2004;92:682-687.
29. Thomas KB, Sutor AH, Altinkaya N, et al. Von Willebrand factorcollagen binding activity is increased in newborns and infants. Acta Paediatr. 1995;84:697-699.
30. Lowe GD, Lee AJ, Rumley A, et al. Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study. Br J Haematol. 1997;96:168-173.
31. Cvirn G, Gallistl S, Koestenberger M, et al. Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma. Thromb Res. 2002;105:433-439.
32. Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med. 2004;14:18-22.
33. Roschitz B, Sudi K, Koestenberger M, et al. Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr. 2001;90:664-670.
34. Borzini P, Lazzaro A, Mazzucco L, et al. The in-vitro bleeding time for the screening of platelet function in the newborn: assessment of a normal reference range. Eur J Pediatr. 2001;160:199-200.